Cerebral amyloid angiopathy (CAA) is a cerebrovascular ... research that has important implications for both diagnosis and treatment. Recent studies have elucidated aspects of the mechanistic ...

No neurofibrillary tangles or amyloid plaques were found in the parenchyma ... magnetic gait and hypertonia of the extremities, treatment with dexamethasone (2 × 4 mg/day) was started.

As multiple companies vie to expand on Alnylam’s success in commercializing RNAi therapeutics, the pioneering company has set ...

Current treatment options are limited ... “OCT looks forward to contributing to research in cerebral amyloid angiopathy, which is a common cause of spontaneous bleeding in the brain and is ...

Cerebral amyloid angiopathy (CAA) has never been more relevant ... given that any potential window for treatment is likely to be at earlier stages of the disease, this is likely to significantly limit ...

The advent of ATTR-specific drugs, though pricey, is enabling better survival in these overlapping diseases, researchers say.

Aortic valve narrowing (aortic stenosis) with concomitant cardiac amyloidosis is a severe heart disease of old age that is ...

and the risk for adverse effects from treatment. The FDA found that the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is substantially equivalent to the Lumipulse G β-amyloid Ratio (1-42/1-40 ...

The drugmaker's approved treatment, Kisunla (donanemab), works by binding to deposited amyloid plaque in the brain. Its phase 3 Alzheimer's asset, remternetug, also binds to amyloid plaques.

which is developing ALN-APP in collaboration with Regeneron for both Alzheimer’s and related condition cerebral amyloid angiopathy (CAA), which can cause haemorrhaging in the brain. Eisai and ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

The Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma Ratio ... evaluations or additional tests should be used for determining treatment options. The Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma ...